Tagged with P

Pharma Han Brouwer, General Manager for Actelion in the Netherlands, explains how Opsumit’s successful market launch has strengthened Actelion’s leadership position in the pulmonary arterial hypertension (PAH) field. He calls for a more comprehensive approach to the disease life cycle and for more transparency during market access procedures while the Dutch…

Pharma Click here to read more articles and interviews from Puerto Rico, and to download the latest free pharma report on the country. 

Puerto Rico Click here to read more articles and interviews from Puerto Rico, and to download the latest free pharma report on the country. 

Puerto Rico Click here to read more articles and interviews from Puerto Rico, and to download the latest free pharma report on the country. 

Thailand Click here to read more articles and interviews from Thailand, and to download the latest free pharma report on the country.

Pharma Click here to read more articles and interviews from Peru, and to download the latest free pharma report on the country. 

Pharma Fabrizio Greco, General Manager at AbbVie Italy, discusses the successful launch of the company’s new Hepatitis C treatment, how AbbVie is seeking to position itself as a partner to the authorities, and where the company’s next generation of growth drivers will be found. To start off, we are approaching the…

Pharma Enrique Hausermann, CEO of EG, the Stada Group’s Italian affiliate for its generics business, discusses the progress the company has made since 2009, the promising areas for growth he sees emerging and the market environment for generics companies in Italy today. When we last spoke in 2009, you told us…

Puerto Rico As healthcare costs are on average 40 percent cheaper in Puerto Rico compared to the mainland US, the island offers plenty of opportunities for treating patients, both from the mainland US as well as those from across the Caribbean region.   Many people come to Puerto Rico for complex surgeries,…

Pharma Patrice Carayon, CEO of Chiesi France, reveals how Chiesi is one of a select few international mid-size pharmaceutical companies in France to have both an R&D and production footprint to accompany its commercial activities; how they will look to continue to establish themselves in their three main areas: respiratory diseases,…

Pharma Medical Union Pharmaceuticals (MUP) acquired Lilly’s Egyptian human insulin vial manufacturing facility in early 2015. Managing Director Ahmed Kelani discusses the national significance of this acquisition given Egypt’s high prevalence of diabetes, and how the transferred technology will support MUP’s ambition to become a leading pharmaceutical manufacturer in the region.…

Pharma A leading consultant to IMS and Professor at Paris Dauphine University reveals how the French healthcare system is moving in two main strategic directions: increasingly relying on private funding through complementary health insurance, and breaking with the egalitarian principle that everybody should be reimbursed to the same extent irrespective of…